S. Wilkie

发表

Chimeric Antigen Receptor aTumor-Associated MUC 1 : The Evolution of Retargeting of Human T Cells to Burchell and

J. Taylor‐Papadimitriou, S. Mather, J. Maher, 2008 .

Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4*

J. Spicer, J. Maher, David M. Davies, 2010, The Journal of Biological Chemistry.

Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice

S. Mather, J. Maher, J. Burnet, 2011, Journal of Clinical Immunology.

Colorimetric determination of agarose-immobilized proteins by formation of copper-protein complexes.

D. Marciani, S. Wilkie, C. L. Schwartz, 1983, Analytical biochemistry.

Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cells.

J. Taylor‐Papadimitriou, J. Maher, J. Burchell, 2011, Biotechnology and bioengineering.

University of Dundee Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK 1-dependent phosphorylation and activation

A. Prescott, H. Walden, M. Peggie, 2015 .

Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation

A. Prescott, D. V. van Aalten, D. Alessi, 2015, EMBO reports.

RB activation defect in tumor cell lines

S. Mittnacht, S. Wilkie, C. Broceño, 2002, Proceedings of the National Academy of Sciences of the United States of America.

pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F

S. Mittnacht, M. Ellis, Y. Chew, 1998, Oncogene.

Reverse Transcriptase-PCR Analysis of Bacterial rRNA for Detection and Characterization of Bacterial Species in Arthritis Synovial Tissue

E. Zanders, M. Hurle, J. Crowe, 2000, Infection and Immunity.

Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogs.

C. Rees, D. Boothe, R. Green, 2003, Veterinary therapeutics : research in applied veterinary medicine.

Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses.

C. Davis, D. Boothe, S. Wilkie, 2001, Veterinary therapeutics : research in applied veterinary medicine.

Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.

H. Boothe, D. Boothe, S. Jones, 2002, Veterinary therapeutics : research in applied veterinary medicine.

Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor1

Sylvain Julien, John Maher, J. Taylor‐Papadimitriou, 2008, The Journal of Immunology.

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

S. Eccles, S. Eccles, M. van Schalkwyk, 2012, Journal of Clinical Immunology.

Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.

H. Boothe, D. Boothe, S. Wilkie, 2001, Veterinary therapeutics : research in applied veterinary medicine.

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin

S. Ghaem-Maghami, M. van Schalkwyk, L. Whilding, 2013, The Journal of Immunology.

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

S. Eccles, J. Maher, C. Box, 2012, Journal of Clinical Immunology.

CAR mechanics: driving T cells into the MUC of cancer.

J. Maher, S. Wilkie, 2009, Cancer research.

In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors.

C. Vogel, S. Wilkie, A. Morgan, 1985, Haematology and blood transfusion.

Modified two step N-acetylcysteine dosing regimen for the treatment of acetaminophen overdose a safe alternative

K. Weant, A. Bailey, R. Baum, 2018 .

Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells

S. Eccles, M. van Schalkwyk, S. Mather, 2012, Molecular medicine.

Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

S. Ghaem-Maghami, S. Mather, L. Whilding, 2013, The Journal of Immunology.

ErbB-Retargeted Human T Cells : Identifying Release Syndrome Induced by Preclinical In Vivo Modeling of Cytokine

S. Ghaem-Maghami, S. Mather, J. Maher, 2013 .

Carboplatin ErbB-Retargeted T Cells Combined with Epithelial Ovarian Cancer Using Synergistic Chemoimmunotherapy of Ghaem-Maghami and

Sadaf, L. Whilding, J. Maher, 2013 .

Use of retroviral-mediated gene transfer to deliver and test function of chimeric antigen receptors in human T-cells

J. Maher, David M. Davies, Ana C. Parente-Pereira, 2014 .

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells.

J. Taylor‐Papadimitriou, J. Maher, J. Burchell, 2016, Immunity.

Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs.

D. Boothe, S. Wilkie, A. Boeckh, 2001, Veterinary therapeutics : research in applied veterinary medicine.

Nitric oxide generation in a rat model of acute portal hypertension.

H. Boothe, D. Boothe, M. Slater, 2000, American journal of veterinary research.

Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization.

C. Smith, E. Petrella, C. Vogel, 1987, Journal of immunological methods.